Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes

被引：0
|
作者：
Özlem Seçilmiş Kerimoğlu
Cihangir Mutlu Ercan
Uğur Keskin
Cem Korkmaz
Namık Kemal Duru
Ali Ergün
机构：
[1] Selçuk University Medicine Faculty,Department of Obstetrics and Gynecology
[2] Gülhane Military Medicine Faculty,Department of Obstetrics and Gynecology
[3] Gülhane Military Medicine Faculty,Department of Histology and Embryology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 288卷
关键词：
Antagonist; Cetrorelix; In vitro fertilization; LH surge;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 695
页数：4
相关论文
共 50 条
  • [1] Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes
    Kerimoglu, Ozlem Secilmis
    Ercan, Cihangir Mutlu
    Keskin, Ugur
    Korkmaz, Cem
    Duru, Namik Kemal
    Ergun, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (03) : 691 - 695
  • [2] Effect of a low gonadotrophin releasing hormone antagonist dose on in-vitro fertilization outcomes
    Kerimoglu, O. Secilmis
    Ercan, C. M.
    Keskin, U.
    Korkmaz, C.
    Duru, N. K.
    Ergun, A.
    HUMAN REPRODUCTION, 2012, 27
  • [3] Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation
    Seng, Shay Way
    Ong, Kee Jiet
    Ledger, W. L.
    WOMENS HEALTH, 2006, 2 (06) : 881 - 888
  • [4] Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization
    Mohamed, KA
    Davies, WAR
    Lashen, H
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (02) : 57 - 62
  • [5] Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration
    Propst, Anthony M.
    Hill, Micah J.
    Bates, Gordon Wright
    Palumbo, Michelle
    Van Horne, Anne K.
    Retzloff, Matthew G.
    FERTILITY AND STERILITY, 2011, 96 (04) : 898 - 904
  • [6] IMPACT OF REVISED START CRITERIA FOR GONADOTROPIN-RELEASING HORMONE ANTAGONIST ON IN VITRO FERTILIZATION OUTCOMES.
    Fortin, Chelsea N.
    Dinh, Duyhoang Q.
    Henderson, Nicholas
    Moravek, Molly B.
    FERTILITY AND STERILITY, 2021, 116 (03) : E252 - E252
  • [7] Pretreatment with estrogen does not affect in vitro fertilization cycle outcomes in gonadotropin releasing hormone antagonist protocols
    Cedrin-Durnerin, I.
    Guivarch, A.
    Hugues, J. N.
    Bstandig, B.
    Parneix, I.
    Vasseur, C.
    Dubourdieu, S.
    Colombel, A.
    HUMAN REPRODUCTION, 2011, 26 : I47 - I47
  • [8] The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome
    Tannus, Samer
    Weissman, Ariel
    Boaz, Mona
    Horowitz, Eran
    Ravhon, Amir
    Golan, Abraham
    Levran, David
    FERTILITY AND STERILITY, 2013, 99 (03) : 725 - 730
  • [9] In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle
    Kummer, Nicole E.
    Weitzman, Vanessa N.
    Benadiva, Claudio A.
    Schmidt, David W.
    Engmann, Lawrence L.
    Nulsen, John C.
    FERTILITY AND STERILITY, 2011, 95 (08) : 2592 - 2594
  • [10] Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles
    Lee, Tsung-Hsien
    Wu, Ming-Yih
    Chen, Hsin-Fu
    Chen, Shee-Uan
    Ho, Hong-Nerng
    Yang, Yu-Shih
    FERTILITY AND STERILITY, 2006, 86 (04) : 1020 - 1022
12345